World's Best Scientists 2026 revealed!
Dolores J. Schendel

Dolores J. Schendel

D-Index & Metrics

Biology and Biochemistry

D-Index
56
Citations
10789
World Ranking
14471
National Ranking
1026

Dolores J. Schendel publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Dolores J. Schendel sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 210 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Dolores J. Schendel D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Dolores J. Schendel sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 56 D-Index — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Dolores J. Schendel is affiliated with Medigene AG in Germany and has an extensive publication record primarily in the fields of Medicine and Immunology and Microbiology. Their research spans multiple subfields, including Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine, and Hematology.

Key topics addressed in their work include:

  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • Immune Cell Function and Interaction
  • RNA Interference and Gene Delivery
  • Biosimilars and Bioanalytical Methods
  • T-cell and B-cell Immunology

Their collaborative network features several frequent co-authors, notably Giulia Longinotti, Kathrin Davari, Petra U. Prinz, Gunnar Kvalheim, and Iris Bigalke, reflecting ongoing partnerships in related immunological and oncological research.

Frequent venues for Dolores J. Schendel's publications include:

  • Regular and Young Investigator Award Abstracts
  • Annals of Oncology
  • Cancer Research
  • Cancers
  • Blood

Selected recent papers exemplify the focus on immunotherapy and cancer treatment strategies:

  • "Development of a CD8 co-receptor independent T-cell receptor specific for tumor-associated antigen MAGE-A4 for next generation T-cell-based immunotherapy," 2021, Journal for ImmunoTherapy of Cancer
  • "Toll-like receptor 7/8-matured RNA-transduced dendritic cells as post-remission therapy in acute myeloid leukaemia: results of a phase I trial," 2020, Clinical & Translational Immunology
  • "Long-term first-in-man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high-risk prostate cancer after radical prostatectomy," 2021, The Prostate
  • "WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapy," 2023, Leukemia
  • "Systemic antitumor effect by regional hyperthermia combined with low-dose chemotherapy and immunologic correlates in an adolescent patient with rhabdomyosarcoma - a case report," 2020, International Journal of Hyperthermia

Best Publications

  • Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy.

    Richard A. Morgan;Nachimuthu Chinnasamy;Daniel Abate-Daga;Alena Gros

  • Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells

    Andreas Moosmann;Iris Bigalke;Johanna Tischer;Leah Schirrmann

  • Pharmacologic Inhibition of MALT1 Protease by Phenothiazines as a Therapeutic Approach for the Treatment of Aggressive ABC-DLBCL

    Daniel Nagel;Stefani Spranger;Michelle Vincendeau;Michael Grau

  • Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.

    Sacha Gnjatic;Vincenzo Bronte;Laura Rosa Brunet;Marcus O. Butler

  • Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients.

    J Endl;H Otto;G Jung;B Dreisbusch

  • Defining the critical hurdles in cancer immunotherapy

    Bernard A. Fox;Bernard A. Fox;Dolores J. Schendel;Lisa H. Butterfield;Steinar Aamdal

  • Effects of galactooligosaccharide and long-chain fructooligosaccharide supplementation during pregnancy on maternal and neonatal microbiota and immunity—a randomized, double-blind, placebo-controlled study

    Rania Shadid;Monique Haarman;Jan Knol;Winfried Theis

  • Cytotoxic Markers and Frequency Predict Functional Capacity of Natural Killer Cells Infiltrating Renal Cell Carcinoma

    Julia S. Schleypen;Nicole Baur;Robert Kammerer;Peter J. Nelson

  • Prostate cancer lesions are surrounded by FOXP3+, PD-1+ and B7-H1+ lymphocyte clusters

    Kathleen Ebelt;Gregor Babaryka;Bernhard Frankenberger;Christian G. Stief

  • Generation of clinical grade dendritic cells with capacity to produce biologically active IL-12p70.

    Anke Zobywalski;Miran Javorovic;Bernhard Frankenberger;Heike Pohla

  • Allele-specific peptide ligand motifs of HLA-C molecules.

    Kirsten Falk;Olaf Rotzschke;Blazenka Grahovac;Dolores Schendel

  • Designer T cells by T cell receptor replacement.

    Daniel Sommermeyer;Julia Neudorfer;Monika Weinhold;Monika Weinhold;Matthias Leisegang

  • Double suicide gene (cytosine deaminase and herpes simplex virus thymidine kinase) but not single gene transfer allows reliable elimination of tumor cells in vivo.

    W. Uckert;T. Kammertöns;K. Haack;Z. Qin

  • Renal cell carcinoma-infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes.

    Julia S Schleypen;Marion Von Geldern;Elisabeth H Weiss;Nicole Kotzias

  • CXC Chemokine Receptor 4 is Essential for Maintenance of Renal cell Carcinoma-Initiating Cells and Predicts Metastasis

    Maximilian Gassenmaier;Dong Chen;Alexander Buchner;Lynette Henkel

  • Human renal cell carcinoma antigen-specific CTLs: antigen-driven selection and long-term persistence in vivo.

    Petra Jantzer;Dolores J. Schendel

  • NK Cell Activity During Human Cytomegalovirus Infection Is Dominated by US2–11-Mediated HLA Class I Down-Regulation

    Christine S. Falk;Michael Mach;Dolores J. Schendel;Elisabeth H. Weiss

  • Dendritic cells pulsed with RNA encoding allogeneic MHC and antigen induce T cells with superior antitumor activity and higher TCR functional avidity

    Susanne Wilde;Daniel Sommermeyer;Bernhard Frankenberger;Matthias Schiemann

  • Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers

    Lisa H. Butterfield;A. Karolina Palucka;A. Karolina Palucka;Cedrik M. Britten;Madhav V. Dhodapkar

  • MHC-restricted fratricide of human lymphocytes expressing survivin-specific transgenic T cell receptors

    Matthias Leisegang;Susanne Wilde;Stefani Spranger;Slavoljub Milosevic

Frequent Co-Authors

Wolfgang Uckert
Wolfgang Uckert Max Delbrück Center for Molecular Medicine
Gunnar Kvalheim
Gunnar Kvalheim Oslo University Hospital
Thomas Blankenstein
Thomas Blankenstein Max Delbrück Center for Molecular Medicine
Christine S. Falk
Christine S. Falk Hannover Medical School
Daniel Krappmann
Daniel Krappmann Ludwig-Maximilians-Universität München
Bernard A. FoxEarle
Bernard A. FoxEarle Earle A. Chiles Research Institute
Christian G. Stief
Christian G. Stief Ludwig-Maximilians-Universität München
Mary L. Disis
Mary L. Disis University of Washington
Jon M. Wigginton
Jon M. Wigginton Bristol-Myers Squibb (Germany)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry opens the door to a wide array of online degree programs and career directions in the health and life sciences sectors. For those interested in applying biological research to human health and well-being, consider exploring the best online nutrition programs. These programs provide a solid foundation in nutritional science, often leading to roles in healthcare, wellness, and food industries.

For students aspiring to move into leadership and healthcare management, top cahme-accredited mha programs offer specialized training in health administration, policy, and organizational leadership. Advanced nursing professionals can elevate their careers through online dnp programs, giving them the chance to focus on leadership, administration, and healthcare innovation without the need for intensive clinical hours.

Finally, those seeking the highest levels of expertise in healthcare management may pursue a doctorate in healthcare administration online. This pathway enables graduates to influence policy, conduct research, and lead large healthcare organizations. These related online degrees empower Biology and Biochemistry students to thrive in evolving and interdisciplinary career paths.

Best Scientists Citing Dolores J. Schendel

Trending Scientists

Recently Published Articles